The University of Minnesota finalises second license with startup International Cardio for ultrasound technology to tackle artery disease.
The University of Minnesota has finalised a second license with International Cardio Corporation (ICC) for an ultrasound-based technology which could benefit millions with artery disease.
It follows a license in 2011 between the two for technologies which treat plaque build-up in the artery walls. The build-up leads to peripheral artery disease, a condition that affects over eight million in the US and is common with Americans suffering from diabetes.
Dennis Sellke, chief executive of ICC, said: “We were very excited…
